Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Myofascial pain with referral from the anterior digastric muscle mimicking a toothache in the mandibular anterior teeth: a case report.

Kalladka M, Thondebhavi M, Ananthan S, Kalladka G, Khan J.

Quintessence Int. 2020;51(1):56-62. doi: 10.3290/j.qi.a43615.

PMID:
31781688
2.

A Novel Mu-Delta Opioid Agonist Demonstrates Enhanced Efficacy With Reduced Tolerance and Dependence in Mouse Neuropathic Pain Models.

Lei W, Vekariya RH, Ananthan S, Streicher JM.

J Pain. 2019 Jun 12. pii: S1526-5900(19)30745-X. doi: 10.1016/j.jpain.2019.05.017. [Epub ahead of print]

PMID:
31201990
3.

Minimally Invasive Trigeminal Ablation: Long Buccal Nerve.

Bresler AY, Kuchukulla M, Ananthan S, Heir G, Paskhover B.

J Oral Facial Pain Headache. 2019 Summer;33(3):e19–e22. doi: 10.11607/ofph.2341. Epub 2019 Apr 24.

PMID:
31017987
4.

A large-scale analysis of bioinformatics code on GitHub.

Russell PH, Johnson RL, Ananthan S, Harnke B, Carlson NE.

PLoS One. 2018 Oct 31;13(10):e0205898. doi: 10.1371/journal.pone.0205898. eCollection 2018.

5.

Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142.

Moerke MJ, Ananthan S, Banks ML, Eltit JM, Freitas KC, Johnson AR, Saini SK, Steele TWE, Negus SS.

J Pharmacol Exp Ther. 2018 Nov;367(2):222-233. doi: 10.1124/jpet.118.250902. Epub 2018 Aug 27.

6.

Orbital pseudotumor presenting as a temporomandibular disorder: A case report and review of literature.

Kalladka M, Ananthan S, Eliav E, Nasri-Heir C, Khan J, Heir G.

J Am Dent Assoc. 2018 Nov;149(11):983-988. doi: 10.1016/j.adaj.2018.05.016. Epub 2018 Jul 25. Review.

PMID:
30055762
7.

Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain.

Zhang W, Lu W, Ananthan S, Suto MJ, Li Y.

Oncotarget. 2017 Sep 6;8(53):91459-91470. doi: 10.18632/oncotarget.20665. eCollection 2017 Oct 31.

8.

Efficacy of the twin block, a peripheral nerve block for the management of chronic masticatory myofascial pain: A case series.

Kanti V, Ananthan S, Subramanian G, Quek SYP.

Quintessence Int. 2017 Oct 6:725-729. doi: 10.3290/j.qi.a39094. [Epub ahead of print]

PMID:
28990015
9.

The role of human dopamine transporter in NeuroAIDS.

Zhu J, Ananthan S, Zhan CG.

Pharmacol Ther. 2018 Mar;183:78-89. doi: 10.1016/j.pharmthera.2017.10.007. Epub 2017 Oct 5. Review.

10.

Hu antigen R (HuR) multimerization contributes to glioma disease progression.

Filippova N, Yang X, Ananthan S, Sorochinsky A, Hackney JR, Gentry Z, Bae S, King P, Nabors LB.

J Biol Chem. 2017 Oct 13;292(41):16999-17010. doi: 10.1074/jbc.M117.797878. Epub 2017 Aug 8.

11.

Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter.

Sun WL, Quizon PM, Yuan Y, Zhang W, Ananthan S, Zhan CG, Zhu J.

Sci Rep. 2017 Jun 16;7(1):3694. doi: 10.1038/s41598-017-03771-0.

12.

Continuous neuropathic pain secondary to endoscopic procedures: report of two cases and review of the literature.

Kalladka M, Nasri-Heir C, Eliav E, Ananthan S, Viswanath A, Heir G.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Aug;122(2):e55-9. doi: 10.1016/j.oooo.2016.05.012. Epub 2016 May 24. Review.

PMID:
27422430
13.

Burning mouth syndrome: Current concepts.

Nasri-Heir C, Zagury JG, Thomas D, Ananthan S.

J Indian Prosthodont Soc. 2015 Oct-Dec;15(4):300-7. doi: 10.4103/0972-4052.171823. Review.

14.

Discovery of a novel inhibitor of kinesin-like protein KIFC1.

Zhang W, Zhai L, Wang Y, Boohaker RJ, Lu W, Gupta VV, Padmalayam I, Bostwick RJ, White EL, Ross LJ, Maddry J, Ananthan S, Augelli-Szafran CE, Suto MJ, Xu B, Li R, Li Y.

Biochem J. 2016 Apr 15;473(8):1027-35. doi: 10.1042/BJ20150992. Epub 2016 Feb 4.

15.

Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells.

Li Y, Lu W, Saini SK, Moukha-Chafiq O, Pathak V, Ananthan S.

Oncotarget. 2016 Mar 8;7(10):11263-70. doi: 10.18632/oncotarget.7019.

16.

Efficacy of regional nerve block in management of myofascial pain of masseteric origin.

Quek SY, Subramanian G, Patel J, Ananthan S, Zagury JG, Khan J.

Cranio. 2015 Oct;33(4):285-90. doi: 10.1080/08869634.2015.1097300. Epub 2015 Dec 29.

PMID:
26715419
17.

The dopamine D3 receptor antagonist, SR 21502, facilitates extinction of cocaine conditioned place preference.

Galaj E, Haynes J, Nisanov R, Ananthan S, Ranaldi R.

Drug Alcohol Depend. 2016 Feb 1;159:263-6. doi: 10.1016/j.drugalcdep.2015.11.030. Epub 2015 Dec 10.

18.

Pramipexole at a Low Dose Induces Beneficial Effect in the Harmaline-induced Model of Essential Tremor in Rats.

Kosmowska B, Wardas J, Głowacka U, Ananthan S, Ossowska K.

CNS Neurosci Ther. 2016 Jan;22(1):53-62. doi: 10.1111/cns.12467. Epub 2015 Oct 13.

19.

The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.

Galaj E, Manuszak M, Babic S, Ananthan S, Ranaldi R.

Drug Alcohol Depend. 2015 Nov 1;156:228-233. doi: 10.1016/j.drugalcdep.2015.09.011. Epub 2015 Sep 25.

20.

Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.

Schreiber SL, Kotz JD, Li M, Aubé J, Austin CP, Reed JC, Rosen H, White EL, Sklar LA, Lindsley CW, Alexander BR, Bittker JA, Clemons PA, de Souza A, Foley MA, Palmer M, Shamji AF, Wawer MJ, McManus O, Wu M, Zou B, Yu H, Golden JE, Schoenen FJ, Simeonov A, Jadhav A, Jackson MR, Pinkerton AB, Chung TD, Griffin PR, Cravatt BF, Hodder PS, Roush WR, Roberts E, Chung DH, Jonsson CB, Noah JW, Severson WE, Ananthan S, Edwards B, Oprea TI, Conn PJ, Hopkins CR, Wood MR, Stauffer SR, Emmitte KA; NIH Molecular Libraries Project Team.

Cell. 2015 Jun 4;161(6):1252-65. doi: 10.1016/j.cell.2015.05.023. Review.

21.

Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.

Rothman RB, Ananthan S, Partilla JS, Saini SK, Moukha-Chafiq O, Pathak V, Baumann MH.

J Pharmacol Exp Ther. 2015 Jun;353(3):529-38. doi: 10.1124/jpet.114.222299. Epub 2015 Mar 18.

22.

Crystal structure of 3-methyl-2,6-bis-(4-methyl-1,3-thia-zol-5-yl)piperidin-4-one.

Manimaran A, Sethusankar K, Ganesan S, Ananthan S.

Acta Crystallogr Sect E Struct Rep Online. 2014 Aug 30;70(Pt 9):o1055. doi: 10.1107/S1600536814018856. eCollection 2014 Sep 1.

23.

Unique functional and structural properties of the LRRK2 protein ATP-binding pocket.

Liu Z, Galemmo RA Jr, Fraser KB, Moehle MS, Sen S, Volpicelli-Daley LA, DeLucas LJ, Ross LJ, Valiyaveettil J, Moukha-Chafiq O, Pathak AK, Ananthan S, Kezar H, White EL, Gupta V, Maddry JA, Suto MJ, West AB.

J Biol Chem. 2014 Nov 21;289(47):32937-51. doi: 10.1074/jbc.M114.602318. Epub 2014 Sep 16.

24.

Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.

Ananthan S, Saini SK, Zhou G, Hobrath JV, Padmalayam I, Zhai L, Bostwick JR, Antonio T, Reith ME, McDowell S, Cho E, McAleer L, Taylor M, Luedtke RR.

J Med Chem. 2014 Aug 28;57(16):7042-60. doi: 10.1021/jm500801r. Epub 2014 Aug 15.

25.

Lifting the mask: identification of new small molecule inhibitors of uropathogenic Escherichia coli group 2 capsule biogenesis.

Goller CC, Arshad M, Noah JW, Ananthan S, Evans CW, Nebane NM, Rasmussen L, Sosa M, Tower NA, White EL, Neuenswander B, Porubsky P, Maki BE, Rogers SA, Schoenen F, Seed PC.

PLoS One. 2014 Jul 1;9(7):e96054. doi: 10.1371/journal.pone.0096054. eCollection 2014.

26.

The novel dopamine D3 receptor antagonist, SR 21502, reduces cocaine conditioned place preference in rats.

Hachimine P, Seepersad N, Ananthan S, Ranaldi R.

Neurosci Lett. 2014 May 21;569:137-41. doi: 10.1016/j.neulet.2014.03.055. Epub 2014 Apr 2.

PMID:
24704326
27.

3-Isopropyl-1-{2-[(1-methyl-1H-tetra-zol-5-yl)sulfan-yl]acet-yl}-2,6-di-phenyl-piperidin-4-one hemihydrate.

Ganesan S, Sugumar P, Ananthan S, Ponnuswamy MN.

Acta Crystallogr Sect E Struct Rep Online. 2013 Oct 2;69(Pt 11):o1598. doi: 10.1107/S1600536813026500. eCollection 2013 Oct 2.

28.

The effects of the novel DA D3 receptor antagonist SR 21502 on cocaine reward, cocaine seeking and cocaine-induced locomotor activity in rats.

Galaj E, Ananthan S, Saliba M, Ranaldi R.

Psychopharmacology (Berl). 2014 Feb;231(3):501-10. doi: 10.1007/s00213-013-3254-y. Epub 2013 Sep 15.

PMID:
24037509
29.

N-(pyridin-4-yl)benzo[d]thiazole-6-carboxamide inhibits E. coli UT189 bacterial capsule biogenesis.

Noah JW, Ananthan S, Evans CW, Nebane NM, Rasmussen L, Sosa M, Tower NA, White EL, Seed P, Goller C, Arshad M, Datta A, Neuenswander B, Porubsky P, Maki BE, Liu C, Rogers SA, Schoenen F, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Dec 17 [updated 2013 Apr 5].

30.

3,3'-{[(Biphenyl-2,2'-di-yl)bis-(methyl-ene)]bis-(-oxy)}bis-[N-(4-chloro-phen-yl)benzamide].

Rajadurai R, Padmanabhan R, Meenakshi Sundaram SS, Ananthan S.

Acta Crystallogr Sect E Struct Rep Online. 2013 May 18;69(Pt 6):o914-5. doi: 10.1107/S160053681301009X. Print 2013 Jun 1.

31.

3,5-Dimethyl-1-{2-[(5-methyl-1,3,4-thia-diazol-2-yl)sulfan-yl]acet-yl}-2,6-diphenylpiperidin-4-one.

Ganesan S, Sugumar P, Ananthan S, Ponnuswamy MN.

Acta Crystallogr Sect E Struct Rep Online. 2013 May 11;69(Pt 6):o845. doi: 10.1107/S1600536813012014. Print 2013 Jun 1.

32.

3-(2,6-difluorobenzamido)-5-(4-ethoxyphenyl) thiophene-2-carboxylic acid inhibits E.coli UT189 bacterial capsule biogenesis.

Noah JW, Ananthan S, Evans CW, Nebane NM, Rasmussen L, Sosa M, Tower NA, White EL, Seed P, Goller C, Datta A, Neuenswander B, Porubsky P, Maki BE, Rogers SA, Schoenen F, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Apr 16 [updated 2013 Mar 14].

33.

Discovery and Development of Highly Potent Inhibitors of Mycobacterium tuberculosis Growth In Vitro.

White EL, Maddox C, Nebane NM, Tower NA, McKellip S, Manuvakhova A, Reddy L, Sosa M, Rasmussen L, Whig K, Ananthan S, Lun S, Bishai W, Weiner WS, Schoenen F, Dutta A, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2011 Apr 15 [updated 2013 Mar 7].

34.

A Cell Based HTS Approach for the Discovery of New Inhibitors of RSV.

Noah JW, Severson W, Chung DH, Moore B, Jia F, Xu X, Maddox C, Rasmussen L, Sosa MI, Tower NA, Ananthan S, White EL, Jonsson C, Matharu DS, Golden JE, Prisinzano TE, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2011 Apr 15 [updated 2013 Feb 28].

35.

Identification of a Series of Quinazolinediones as Potent, Selective, Post-Entry Inhibitors of Human Respiratory Syncytial Virus (hRSV) via a Cell-Based High Throughput Screen and Chemical Optimization.

Noah JW, Severson WE, Chung DH, Moore B, Jia F, Xu X, Maddox C, Rasmussen L, Sosa MI, Tower NA, Ananthan S, Evans CW, White EL, Jonsson C, Matharu DS, Flaherty DP, Simpson DS, Golden JE, Aubé J.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2011 Dec 16 [updated 2013 Feb 28].

36.

A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus.

Chung DH, Moore BP, Matharu DS, Golden JE, Maddox C, Rasmussen L, Sosa MI, Ananthan S, White EL, Jia F, Jonsson CB, Severson WE.

Virol J. 2013 Jan 10;10:19. doi: 10.1186/1743-422X-10-19.

37.

(S)-N-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a small molecule inhibitor probe for the study of respiratory syncytial virus infection.

Moore BP, Chung DH, Matharu DS, Golden JE, Maddox C, Rasmussen L, Noah JW, Sosa MI, Ananthan S, Tower NA, White EL, Jia F, Prisinzano TE, Aubé J, Jonsson CB, Severson WE.

J Med Chem. 2012 Oct 25;55(20):8582-7. doi: 10.1021/jm300612z. Epub 2012 Oct 16.

38.

Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitors.

Verma VA, Rossman R, Bennett F, Chen L, Gavalas S, Girijavallabhan V, Huang Y, Kim SH, Kosinski A, Pinto P, Rizvi R, Shankar B, Tong L, Velazquez F, Venkatraman S, Kozlowski J, MacCoss M, Kwong CD, Bansal N, Kezar HS 3rd, Reynolds RC, Maddry JA, Ananthan S, Secrist JA 3rd, Li C, Chase R, Curry S, Huang HC, Tong X, Njoroge FG, Arasappan A.

Bioorg Med Chem Lett. 2012 Nov 15;22(22):6967-73. doi: 10.1016/j.bmcl.2012.08.111. Epub 2012 Sep 7.

PMID:
23036957
39.

14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effects.

Ananthan S, Saini SK, Dersch CM, Xu H, McGlinchey N, Giuvelis D, Bilsky EJ, Rothman RB.

J Med Chem. 2012 Oct 11;55(19):8350-63. doi: 10.1021/jm300686p. Epub 2012 Sep 27.

40.

Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.

Girijavallabhan VM, Alvarez C, Bennett F, Chen L, Gavalas S, Huang Y, Kim SH, Kosinski A, Pinto P, Rizvi R, Rossman R, Shankar B, Tong L, Velazquez F, Venkatraman S, Verma VA, Kozlowski J, Shih NY, Piwinski JJ, MacCoss M, Kwong CD, Bansal N, Clark JL, Fowler AT, Kezar HS 3rd, Valiyaveettil J, Reynolds RC, Maddry JA, Ananthan S, Secrist JA 3rd, Li C, Chase R, Curry S, Huang HC, Tong X, Njoroge FG, Arasappan A.

Bioorg Med Chem Lett. 2012 Sep 1;22(17):5652-7. doi: 10.1016/j.bmcl.2012.06.099. Epub 2012 Jul 15.

PMID:
22858143
41.

Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.

Bennett F, Kezar HS 3rd, Girijavallabhan V, Huang Y, Huelgas R, Rossman R, Shih NY, Piwinski JJ, MacCoss M, Kwong CD, Clark JL, Fowler AT, Geng F, Roychowdhury A, Reynolds RC, Maddry JA, Ananthan S, Secrist JA 3rd, Li C, Chase R, Curry S, Huang HC, Tong X, George Njoroge F, Arasappan A.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):5144-9. doi: 10.1016/j.bmcl.2012.06.021. Epub 2012 Jun 19.

PMID:
22814211
42.

5-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.

Arasappan A, Bennett F, Girijavallabhan V, Huang Y, Huelgas R, Alvarez C, Chen L, Gavalas S, Kim SH, Kosinski A, Pinto P, Rizvi R, Rossman R, Shankar B, Tong L, Velazquez F, Venkatraman S, Verma VA, Kozlowski J, Shih NY, Piwinski JJ, MacCoss M, Kwong CD, Clark JL, Fowler AT, Geng F, Kezar HS 3rd, Roychowdhury A, Reynolds RC, Maddry JA, Ananthan S, Secrist JA 3rd, Li C, Chase R, Curry S, Huang HC, Tong X, Njoroge FG.

Bioorg Med Chem Lett. 2012 May 1;22(9):3229-34. doi: 10.1016/j.bmcl.2012.03.036. Epub 2012 Mar 13.

PMID:
22472692
43.

Novel substituted pyrimidines as HCV replication (replicase) inhibitors.

Kwong CD, Clark JL, Fowler AT, Geng F, Kezar HS 3rd, Roychowdhury A, Reynolds RC, Maddry JA, Ananthan S, Secrist JA 3rd, Shih NY, Piwinski JJ, Li C, Feld B, Huang HC, Tong X, George Njoroge F, Arasappan A.

Bioorg Med Chem Lett. 2012 Jan 15;22(2):1160-4. doi: 10.1016/j.bmcl.2011.11.091. Epub 2011 Dec 1.

PMID:
22178556
44.

N'-[(E)-2-Chloro-benzyl-idene]-2-[(1,3,4-thia-diazol-2-yl)sulfan-yl]acetohydrazide.

Mohan S, Ananthan S, Ramesh P, Saravanan D, Ponnuswamy MN.

Acta Crystallogr Sect E Struct Rep Online. 2011 Oct 1;67(Pt 10):o2612. doi: 10.1107/S1600536811035549. Epub 2011 Sep 14.

45.

High-throughput screening identifies a bisphenol inhibitor of SV40 large T antigen ATPase activity.

Seguin SP, Evans CW, Nebane-Akah M, McKellip S, Ananthan S, Tower NA, Sosa M, Rasmussen L, White EL, Maki BE, Matharu DS, Golden JE, Aubé J, Brodsky JL, Noah JW.

J Biomol Screen. 2012 Feb;17(2):194-203. doi: 10.1177/1087057111421630. Epub 2011 Sep 23.

46.

High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.

Reynolds RC, Ananthan S, Faaleolea E, Hobrath JV, Kwong CD, Maddox C, Rasmussen L, Sosa MI, Thammasuvimol E, White EL, Zhang W, Secrist JA 3rd.

Tuberculosis (Edinb). 2012 Jan;92(1):72-83. doi: 10.1016/j.tube.2011.05.005. Epub 2011 Jun 25.

47.

The role of sensory input of the chorda tympani nerve and the number of fungiform papillae in burning mouth syndrome.

Nasri-Heir C, Gomes J, Heir GM, Ananthan S, Benoliel R, Teich S, Eliav E.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jul;112(1):65-72. doi: 10.1016/j.tripleo.2011.02.035. Epub 2011 May 20.

PMID:
21601494
48.

Recombinant human immunodeficiency virus-1 transactivator of transcription1-86 allosterically modulates dopamine transporter activity.

Zhu J, Ananthan S, Mactutus CF, Booze RM.

Synapse. 2011 Nov;65(11):1251-4. doi: 10.1002/syn.20949. Epub 2011 May 17. No abstract available.

49.

A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus.

Chung DH, Ardecky R, Ganji SR, Cosford NDP, Jonsson CB, Moore BP, Jia F, Maddox C, McKellip SN, White EL, Ananthan S, Feng S, Rasmussen L, Su Y, Chung TDY, Dad S, Tower NA, Heil M.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2010 Feb 27 [updated 2010 Oct 4].

50.

The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking.

Nielsen CK, Simms JA, Bito-Onon JJ, Li R, Ananthan S, Bartlett SE.

Addict Biol. 2012 Mar;17(2):224-34. doi: 10.1111/j.1369-1600.2010.00295.x. Epub 2011 Feb 11.

Supplemental Content

Loading ...
Support Center